Journal of Antimicrobial Chemotherapy (2001) 47, 171-175
© 2001 The British Society for Antimicrobial Chemotherapy
In situ measurement of linezolid and vancomycin concentrations in intravascular catheter-associated biofilm
Department of Microbiology, University of Leeds and The General Infirmary, Leeds LS2 9JT, UK
We describe a new method for the measurement of antimicrobial concentrations in the biofilm associated with the endoluminal surface of intravascular catheters. We quantified endoluminal planktonic bacteria in haemodialysis catheters using the acridine orange method on catheter blood. After catheter removal, separate lumens were perfused in vitro with either vancomycin or linezolid to simulate in vivo antibiotic infusion. Biofilm was recovered using endoluminal brushes, weighed and assayed by fluoroimmunoassay for vancomycin and by bioassay for linezolid. Viable bacteria were counted by serial dilution and agar plating. Biofilm had measurable amounts of vancomycin in 11/11 catheter lumens post-infusion (0.3–18.2 mg biofilm per lumen, mean 6.8 mg; vancomycin concentration 0.2–89 mg/g biofilm, median 19 mg/g). By comparison, linezolid was detected in 4/11 catheter lumens post-infusion (0.5–18.1 mg biofilm per lumen, mean 5.9 mg; linezolid concentration 0.9–6.1 mg/g biofilm, median 1.5 mg/g). Percentage reductions in biofilm-associated bacterial counts post-antibiotic were 84–100%, median 95% (vancomycin) and 0–98%, median 91% (linezolid). We found a significant difference (P = 0.05; Wilcoxon rank sum test) in vancomycin concentrations in coagulase-negative staphylococcal biofilm (median 17.0 mg/g, mean 27.9 mg/g) compared with glycopeptide levels found in biofilm associated with other microorganisms (median 5.5 mg/g, mean 6.9 mg/g). Biofilm concentrations of vancomycin are generally higher than linezolid after antibiotic infusion, which can be explained partly by glycopeptide binding to glycocalyx. Neither antibiotic achieved consistent 100% kill of biofilm bacteria after single infusions, even when a very high concentration was present. The endoluminal brush technique can be used to measure antibiotic concentration in intravascular catheter-associated biofilm in situ. This approach can be exploited to measure biofilm antibiotic concentrations in vivo, without the need for catheter removal.
* Corresponding author. Tel: +44-113-233-5596; Fax: +44-113-233-5649; E-mail: markwi{at}pathology.leeds.ac.uk
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  D. P. Levine Clinical experience with daptomycin: bacteraemia and endocarditis J. Antimicrob. Chemother., November 1, 2008; 62(suppl_3): iii35 - iii39. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Ghiselli, A. Giacometti, O. Cirioni, F. Mocchegiani, C. Silvestri, F. Orlando, W. Kamysz, A. Licci, P. Nadolski, A. Della Vittoria, et al. Pretreatment With the Protegrin IB-367 Affects Gram-Positive Biofilm and Enhances the Therapeutic Efficacy of Linezolid in Animal Models of Central Venous Catheter Infection JPEN J Parenter Enteral Nutr, November 1, 2007; 31(6): 463 - 468. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. L. LaPlante and L. A. Mermel In vitro activity of daptomycin and vancomycin lock solutions on staphylococcal biofilms in a central venous catheter model Nephrol. Dial. Transplant., August 1, 2007; 22(8): 2239 - 2246. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. I. Raad, H. A. Hanna, M. Boktour, G. Chaiban, R. Y. Hachem, T. Dvorak, R. Lewis, and B. E. Murray Vancomycin-Resistant Enterococcus faecium: Catheter Colonization, esp Gene, and Decreased Susceptibility to Antibiotics in Biofilm Antimicrob. Agents Chemother., December 1, 2005; 49(12): 5046 - 5050. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. P. Wiederhold, E. A. Coyle, I. I. Raad, R. A. Prince, and R. E. Lewis Antibacterial activity of linezolid and vancomycin in an in vitro pharmacodynamic model of Gram-positive catheter-related bacteraemia J. Antimicrob. Chemother., May 1, 2005; 55(5): 792 - 795. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Curtin, M. Cormican, G. Fleming, J. Keelehan, and E. Colleran Linezolid Compared with Eperezolid, Vancomycin, and Gentamicin in an In Vitro Model of Antimicrobial Lock Therapy for Staphylococcus epidermidis Central Venous Catheter-Related Biofilm Infections Antimicrob. Agents Chemother., October 1, 2003; 47(10): 3145 - 3148. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Gander, K. Hayward, and R. Finch An investigation of the antimicrobial effects of linezolid on bacterial biofilms utilizing an in vitro pharmacokinetic model J. Antimicrob. Chemother., February 1, 2002; 49(2): 301 - 308. [Abstract] [Full Text] [PDF]
|
|